Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP62693.RAnusRBYRQWlI2I8cSYtU-EpSk_BwHsipgvSaUPeAvcTE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP62693.RAnusRBYRQWlI2I8cSYtU-EpSk_BwHsipgvSaUPeAvcTE130_assertion type Assertion NP62693.RAnusRBYRQWlI2I8cSYtU-EpSk_BwHsipgvSaUPeAvcTE130_head.
- NP62693.RAnusRBYRQWlI2I8cSYtU-EpSk_BwHsipgvSaUPeAvcTE130_assertion description "[We believe these findings may have importance both for the directional pathogenesis of scleroderma progression and for the treatment of scleroderma with anti-TNF agents.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP62693.RAnusRBYRQWlI2I8cSYtU-EpSk_BwHsipgvSaUPeAvcTE130_provenance.
- NP62693.RAnusRBYRQWlI2I8cSYtU-EpSk_BwHsipgvSaUPeAvcTE130_assertion evidence source_evidence_literature NP62693.RAnusRBYRQWlI2I8cSYtU-EpSk_BwHsipgvSaUPeAvcTE130_provenance.
- NP62693.RAnusRBYRQWlI2I8cSYtU-EpSk_BwHsipgvSaUPeAvcTE130_assertion SIO_000772 14872499 NP62693.RAnusRBYRQWlI2I8cSYtU-EpSk_BwHsipgvSaUPeAvcTE130_provenance.
- NP62693.RAnusRBYRQWlI2I8cSYtU-EpSk_BwHsipgvSaUPeAvcTE130_assertion wasDerivedFrom gad-20130706 NP62693.RAnusRBYRQWlI2I8cSYtU-EpSk_BwHsipgvSaUPeAvcTE130_provenance.
- NP62693.RAnusRBYRQWlI2I8cSYtU-EpSk_BwHsipgvSaUPeAvcTE130_assertion wasGeneratedBy ECO_0000203 NP62693.RAnusRBYRQWlI2I8cSYtU-EpSk_BwHsipgvSaUPeAvcTE130_provenance.